Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 29 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Vance Thompson Vision Clear all

Conditions: Dry Eye Disease
Interventions: OC-01 (varenicline 1.2mg/ml) nasal spray vs Placebo, Placebo (vehicle) nasal spray; Drug · Other
Lead sponsor: Vance Thompson Vision - MT; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Bozeman, Montana

Conditions: Presbyopia
Interventions: There is not an intervention; Diagnostic Test
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 37 Years to 48 Years
Enrollment: 45 participants
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Myopia, Astigmatism
Interventions: Contoura with Phorcides, WaveLight Wavefront Optimized; Procedure · Device
Lead sponsor: Daniel Terveen; Other
Eligibility: 21 Years to 38 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 4
States / cities: Bozeman, Montana • Omaha, Nebraska • Fargo, North Dakota + 1 more

Conditions: Anterior Blepharitis
Interventions: NATACYN®; Drug
Lead sponsor: Brent Kramer; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 5
States / cities: Jacksonville, Florida • Pittsburg, Kansas • Mint Hill, North Carolina + 2 more

Conditions: Dry Eye
Interventions: OC-01 (varenicline 0.6mg/ml) nasal spray, Placebo (vehicle) Nasal Spray; Drug
Lead sponsor: Brandon Baartman; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Glaucoma, Cataract, Presbyopia
Interventions: Cataract Surgery with Implantation of Vivity Extended Range of Vision IOL; Procedure
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 45 Years and older
Enrollment: 27 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Ocular Surface Disease, Glaucoma, Open-Angle
Interventions: iStent or iStent inject implantation with concomitant cataract surgery; Device
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 22 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Dry Eye Disease
Interventions: OC-01 (varenicline 0.6mg/ml) nasal spray, Placebo (vehicle) nasal spray; Drug
Lead sponsor: Vance Thompson Vision ND; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: West Fargo, North Dakota

Conditions: Dry Eye Disease (DED)
Interventions: Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML; Device
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 22 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Cataract
Interventions: Vivity ACRYSOF IQ IOL Group, ACRYSOF IQ IOL Control Group; Device
Lead sponsor: John Berdahl, MD; Other
Eligibility: Not listed
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Cataract, Pseudophakia
Interventions: Data collection; Other
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 40 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Dry Eye Syndrome (DES), Dry Eye Disease (DED)
Interventions: Miebo four times per day; Drug
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 4
States / cities: Bozeman, Montana • Omaha, Nebraska • Fargo, North Dakota + 1 more

Conditions: Patient Preference, Patient Outcomes, Post-Operative Inflammation, Grade of Post-Operative Cystoid Macular Edema, Rate of Post-Operative Cystoid Macular Edema
Interventions: Dextenza, Topical Prednisolone; Drug
Lead sponsor: Vance Thompson Vision - MT; Other
Eligibility: 22 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Bozeman, Montana

Conditions: Anterior Blepharitis
Interventions: Not listed
Lead sponsor: Brent Kramer; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 5
States / cities: Jacksonville, Florida • Pittsburg, Kansas • Mint Hill, North Carolina + 2 more

Conditions: Dry Eye
Interventions: Determine the ability of the iTrace™, BOSA™, OPD-Scan III, and IDRA to detect tear film stability utilizing Miebo®; Drug
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Astigmatism, Myopia
Interventions: Wavelight Plus; Device
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 18 Years to 45 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Refractive Errors
Interventions: PanOptix; Device
Lead sponsor: Vance Thompson Vision ND; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: West Fargo, North Dakota

Conditions: Cataract
Interventions: Dextenza 0.4Mg Ophthalmic Insert, Topical prednisolone acetate; Drug
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Refractive Surgery
Interventions: Dextenza 0.4Mg Ophthalmic Insert, Topical Prednisolone; Drug
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Myopia
Interventions: Laser-assisted in Situ Keratomileusis, Implantable Collamer Lens placement; Device
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 21 Years to 45 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 5
States / cities: Omaha, Nebraska • Cleveland, Ohio • Mt. Pleasant, South Carolina + 2 more

Conditions: Cataract
Interventions: PureSee IOL; Device
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 40 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Vital Signs
Interventions: Midazolam/Ketamine HCl 3mg-50mg sublingual, Intravenous Sedatives with or Without Analgesia; Drug
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 55 Years to 80 Years
Enrollment: 1,111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 2
States / cities: Sioux Falls, South Dakota

Conditions: Refractive Surgery
Interventions: Dextenza 0.4Mg Ophthalmic Insert, Topical Prednisolone; Drug
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: West Fargo, North Dakota

Conditions: Cataract, Pseudophakia
Interventions: LAL IOL lens; Procedure
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 18 Years to 110 Years
Enrollment: 25 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Search by objective public record fields.

IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL

Analysis of Defocus Curve of Pre-Presbyopic and Emerging Presbyopic Patients

Contoura With Phorcides Compared to Wavefront Optimized LASIK

Clinical Lid Eradication of Antifungal-Responsive FUNGUS Study

Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)

Vivity Outcomes in Patients With Early Stage Glaucoma

Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification

Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)

Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

Long Term Outcomes of Vivity Intra Ocular Lens(IOL) Versus Control

Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)

A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK

The PRIME Study: A Randomized, Controlled, Prospective Study

Ocular Dysbiosis in Eyelid Disease

BL-RX01-TFSTAB-1402

Evaluation of Mesopic Visual Acuity and Patient Satisfaction Following Ray-Tracing-Guided LASIK

Outcomes of a Trifocal IOL in Post-refractive Patients

In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery

The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study

Measuring Outcomes of LASIK and EVO-ICL in Matched Populations

A Prospective, Single-Arm Clinical Evaluation of Visual, Refractive, and Patient-Reported Outcomes Following Bilateral Implantation of the TECNIS PureSee™ Extended Depth of Focus Intraocular Lens

Exploring Sedation Types During Cataract Surgery

DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery

Binocular Custom Vision Utilizing The Light Adjustable Lens (LAL)